Acute Myeloid Leukemia With NPM1 Mutation Post Cytotoxic Therapy Mimicking CEL , NOS

Key Points

• Mimicking cellular behaviors are observed in the tumor microenvironment following cytotoxic therapy treatments.
• The nPM1 mutation in acute myeloid leukemia alters responses to therapy, complicating patient management.
• Cytotoxic therapies create unique profiles in cellular responses, impacting further treatment strategies.
• Complications may arise from mimicking conditions, highlighting the need for further investigation into therapeutic responses.